Big players in the Alzheimer’s drug market

A new drug to treat Alzheimer’s disease would obviously impact the lives of millions of people in the U.S. affected by the disease. Any significant breakthrough could also mean tens of billions of dollars for the pharmaceutical company that makes it.

Recently, a panel on CNBC discussed the companies currently working on drugs designed to break up amyloid plaques associated with Alzheimer’s and where the research stands:

Visit for breaking news, world news, and news about the economy